Argent Biopharma Ltd has released a press release.
RGT Executes Global CannEpil Licensing Deal for US$5.5M
Earlier from Argent Biopharma
- Half Yearly Report and Accounts
- Provisional Patent Lodged with USPTO for NanoBodies Platform
- CannEpil - Largest Commercial Shipment Arrives in Ireland
- Quarterly Activities/Appendix 4C Cash Flow Report